Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Women are four times more likely to be diagnosed with thyroid cancer than men—but most cases are indolent. Is it overtreatment?
The targeted therapy delayed disease progression or death by approximately nine months.
The response rate was nearly 50% for people with breast, colon, pancreatic and other cancers.
COVID-19, FDA drug approvals and new approaches to treatment and quality of life stood out among this year’s top stories.
After being treated for thyroid cancer with a rare mutation, Susan is helping educate others.
Targeted therapy demonstrated high response rates for thyroid tumors with RET mutations or fusions.
These cancers include those that are rare among adults under 40, such as breast, colon, pancreas, kidney, prostate and ovarian cancer.
These are the latest cancer treatments approved by the FDA.
Selpercatinib, the first drug in its class, shrank tumors in over two thirds of previously treated patients.
The author of a new survey study suggested that using such words may invalidate cancer patients’ experiences.
John Duggan has survived both stage III colon cancer and thyroid cancer before age 30.
New insights may help scientists develop better drugs to intervene in cancers, such as melanoma and thyroid cancer
New site-agnostic therapies highlight the importance of genetic testing.
Mark Ruffalo stars as a lawyer who takes on a chemical giant in this movie inspired by real events.
Those with bladder, larynx, prostate, womb, bowel and breast cancers have the highest rate of death related to cardiovascular disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.